Robert Califf

pharmaceutical Companies

February 25, 2016
Public Citizen’s Dr. Michael Carome describes the thousands in consulting fees new FDA commissioner Dr. Robert Califf received from pharmaceutical manufacturers and why only four senators voted against his confirmation